Julia Scarisbrick

Final results of UK NCRI phase II trial of pembrolizumab and radiotherapy in cutaneous T cell lymphoma

Timothy Illidge, William Wilson, James Paterson, A Bates et autres

The outlook for patients with advanced cutaneous T-cell lymphomas (CTCL); mycosis fungoides (MF) and Sézary syndrome (SS) remains poor and most systemic treatments provide short-lived remissions. Immunotherapy has provided a major cancer breakthrough, and the PORT trial was designed to investigate the …

gb, us (code pays fourni par la source)

Symptom burden in multiple long-term conditions: An AI-supported, mixed-methods concept elicitation study

Sarah E Hughes, Benjamin M A Hughes, Shamil Haroon, Eleanor Hathaway et autres

Objective: To develop the conceptual framework for an MLTC-specific patient-reported outcome measure (PROM), the Symptom Burden Questionnaire™ for MLTC (SBQ™-MLTC). Design: Mixed-methods study: (1) symptom list generation; (2) assessment of list face validity; and (3) construction of a conceptual framework. Setting: Concept …

gb, us (code pays fourni par la source)

Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

Rudolf Stadler, Rudolf Stadler, Pietro Quaglino, F J Sherida H Woei-A-Jin et autres

de, by, be, ch, gr, es, at, jp, gb, fr, us, it, hu, pl (code pays fourni par la source)